The Management of Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide: A Long-Term Cost-Effectiveness Analysis in Slovakia.
Samuel J P MalkinMonika Russel-SzymczykMarek PsotaLucia HlavinkovaBarnaby HuntPublished in: Advances in therapy (2019)
Novo Nordisk A/S.